Valeant Pharma Erases Thursday's Decline After Sale Of iNova Pharma

Loading...
Loading...

Valeant Pharma Inc. VRX shares are trading higher by $0.73 at $14.49 in Friday's session. It has erased all of Thursday's decline of $0.63 and currently a dime over Wednesday's close of $14.39.

The catalyst for the rebound is the announcement of the sale of iPharma. Investors are hopeful the sale would reduce the huge debt that the company accumulated over the years.

After a higher open, it had a brief retreat but found support above Thursday's close ($13.76), only reaching $13.89 before continuing its move higher.

Posted In: TechnicalsIntraday UpdateMoversTrading IdeasValeant Pharma
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...